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A Basis for Alloreactivity:
MHC Helical Residues Broaden
Peptide Recognition by the TCR
nature of peptide, precisely how a T cell receptor (TCR)
recognizes an alloligand remains to be ascertained.
Among several different hypotheses that have been pro-
posed for alloreactivity, the involvement of the peptide
in allorecognition ranges considerably (Matzinger and
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and Paul M. Allen²
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Bevan, 1977; Sherman and Chattopadhyay, 1993; JoyceSt. Louis, Missouri 63110
and Nathenson, 1996; Janeway and Travers, 1997). In
one model, only the peptide is recognized and there is
no contact of the MHC by the TCR. In another model,Summary
only the MHC molecule is recognized and the peptide
is not contacted at all. The 2C system is the most ad-The high frequency of alloreactive T cells is a major
vanced allomodel, with crystal structures for several ofhindrance for transplantation; however, the molecular
the involved molecules having been solved. Substantialbasis for alloreactivity remains elusive. We examined
progress has been made in recent years on the molecu-the I-Ep alloreactivity of a well-characterized Hb(64-
lar description of T cell recognition, and biological stud-76)/I-Ek±specific murine T cell. Using a combinatorial
ies have suggested a diagonal orientation of the TCRpeptide library approach, we identified a highly stimu-
relative to the peptide/MHC complex (Sun et al., 1995;latory alloepitope mimic and observed that the recog-
Hong et al., 1997). This orientation has been establishednition of the central TCR contact residues (P3 and P5)
by crystallographic analysis of the TCR/peptide/MHCwas much more flexible than that seen with Hb(64-
complex (Garboczi et al., 1996; Garcia et al., 1996). In76)/I-Ek, but still specific. Therefore, alloreactive T cells
particular, this analysis has demonstrated the centralcan recognize a self-peptide/MHC surface; however,
location of theTCR CDR3s on thepeptide/MHC complexthe allogeneic MHC molecule changes the recognition
and has provided an explanation for the crucial role ofrequirements for the central region of the peptide,
these TCR loops in determining specificity. Despite thisallowing a more diverse repertoire of ligands to be
structural information, the molecular basis for the recog-recognized.
nition of the alloligands and a foreign antigen mimitope
has not been elucidated (Brock et al., 1996).Introduction
We wanted to examine the involvement of peptides
in class II alloligands. Much less is known about MHCDuring their maturation, thymocytes undergo positive
class II alloreactivity even though it is clinically as impor-and negative selection, which results in a repertoire of
tant as class I (Fink et al., 1986; Matis et al., 1987;peripheral T cells able to interact with complexes made
Braunstein et al., 1990; Panina-Bordignon et al., 1991;of peptides bound to self±major histocompatibility com-
Vella et al., 1997). This is due, in part, to the lack ofplex (MHC) molecules on the surface of antigen-pre-
a class II model antigen system in which two ligandssenting cells (APCs) (Kisielow and von Boehmer, 1995).
recognized by the same TCR are identified and charac-In the context of this selection process, T cell±mediated
terized. The Hb(64-76)/I-Ek antigen system was idealalloreactivity remains enigmatic because alloreactive T
to study class II alloreactivity because of its extensivecells interact with allogeneic MHC molecules to which
biological and biochemical characterization (Lorenz andthey have not previously been exposed. The frequency
Allen, 1988; Wettstein et al., 1991; Evavold et al., 1992)of alloreactive cells is high, with 1%±10% of peripheral
and the available x-ray crystal structure (Fremont et al.,T cells being able to recognize alloantigen (Sherman
1996). Four residues of Hb(64-76) are involved in bindingand Chattopadhyay, 1993).
to the I-Ek molecule, and five are TCR contact residues.Self-peptides bound to MHC molecules play a critical
Of these five TCR contact residues, the primary T cellrole in alloreactivity (Panina-Bordignon et al., 1991;
contact residue is the P5 N residue, located in the centerRoÈ tzschke et al., 1991; Crumpacker et al., 1992; Udaka
of the peptide/MHC surface. A synthetic peptide libraryet al., 1992; Kuzushima et al., 1995; Ignatowicz et al.,
approach was used to identify an alloepitope mimic that1996; Miyazaki et al., 1996). Essentially all progress on
reconstituted the I-Ep alloreactivity of an Hb(64-76)/I-Ek-the identification and characterization of self-peptides
specific T cell. The structures of the alloepitope andin allorecognition has involved MHC class I systems
Hb(64-76) peptide differ considerably at the P3 and P5(Frelinger and McMillan, 1996). In theextensively studied
positions, and recognition is much more flexible in allo-2C allomimitope system, two different allomolecules
reactivity. Moreover, allorecognition is still mediated byand corresponding self-peptides have been identified:
the TCR CDR3s loops. More importantly, we were ableLd/p2Ca and H-2bm3/dEV8 (Udaka et al., 1992; Sykulev
to demonstrate, using an I-Ek molecule containing sixet al., 1994; Tallquist and Pease, 1995; Schlueter et al.,
I-Ep substitutions, that this altered recognition is directly1996).
linked to polymorphic residues of the MHC a helix.Despite the advances made by these studies on the
Results*Present address: Centre de Recherche en Immunologie, Institut
Armand-Frappier, Laval, QueÂbec, Canada H7N 4Z3.
We have previously reported that the T cell 2.102, spe-²To whom correspondence should be addressed (e-mail: allen@
immunology.wustl.edu). cific for the Hb(64-76)/I-Ek complex, was alloreactive
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Figure 1. Identification of an I-Ep-Restricted
Epitope of the b-Galactosidase
(A) The epitope recognized by the T cell hy-
bridoma 1-F2 was mapped on the first 500
residues of the b-galactosidase using a panel
of overlapping 30-mer or 32-mer peptides. (B)
Fine mapping of the 1-F2 hybridoma epitope
using a set of overlapping 13-mer peptides.
(C) Sequence and I-Ep±binding register of the
b-gal(450±462) epitope. Arrows indicate the
MHC anchor residues.
against I-Ep (Daniel et al., 1998). This alloreactivity was residue, similar to other I-E±restricted epitopes that gen-
erally require an aliphatic residue (I, L, or V) at this posi-observed for naive 2.102 T cells from a TCR transgenic
mouse as well as the 2.102 T cell hybridoma. The I-Ep tion (Rammensee et al., 1995; Fremont et al., 1996). The
b-gal(450±462) epitope contains a S residue at the P9molecule has an identical a chain to I-Ek, whereas the
b chain differs at 20 positions (Wei et al., 1996; Daniel anchor residue, in contrast to most other I-E±restricted
epitopes, which have a R or K at this position. Theet al., 1998). Transfection of the B cell lymphoma CH27
(H-2k) with the I-Ep b chain (CH27-Ep) reconstituted 2.102 positively charged residue at this position makes a salt
bridge with the Eb9 conserved in all I-E b chains (FremontT cell alloreactivity (Daniel et al., 1998). However, trans-
fection of CHO cells with I-E a and I-Ep b chains did not et al., 1996). Interestingly, the substitution of the P9 S
with a K completely abolished reactivity (data not shown).reconstitute 2.102 alloreactivity, even though I-Ep was
expressed on the cell surface (data not shown). These According to the deduced binding register, residue S at
position P4 and residue G at position P6 are secondaryresults suggested that 2.102 T cell alloreactivity was
dependent on the recognition of an allopeptide/I-Ep MHC anchors.
complex and that CHO-Ep cells were unable to provide
the allopeptide. Identification of an Allomimotope That Reconstitutes
2.102 T Cell Alloreactivity
Peptide libraries were synthesized and assayed for theirIdentification of an I-Ep±Restricted Epitope
Our first objective was to determine the structural fea- capacity to stimulate 2.102 hybridoma alloreactivity us-
ing the CHO-Ep cell line as APCs. The binding registertures of an allopeptide presented by I-Ep and recognized
by the 2.102 TCR. We chose to identify an epitope mimic of thepeptide libraries was set by using the MHC anchor
residues identified for b-gal(450±462) at positions P1,using the combinatorial peptide library approach (Eva-
vold et al., 1995; Blake et al., 1996; Hemmer et al., 1997). P6, and P9. The first peptide libraries were made by
using either pools of hydrophilic (K, R, D, E, N, and Q)The complexity of such libraries can bereduced by fixing
the residues of the peptide required to bind to the MHC or hydrophobic (I, L, V, and W) residues at P5; a pool
of S, T, and A at P4; and a mixture of 20 amino acidsmolecule. However, neither an I-Ep binding motif nor an
I-Ep±restricted epitope was known. Therefore, we first at P2, P3, P7, and P8. The 2.102 cell line responded
strongly to the peptide library containing the pool ofdefined an I-Ep±restricted epitope using b-galactosidase
as a model antigen. A T cell hybridoma (1-F2) that re- hydrophobic residues at P5, whereas the P5 hydrophilic
library did not stimulate it (Figure 2A). This observationsponded strongly to the b-galactosidase protein in the
context of I-Ep presentation was characterized. The re- confirmed that 2.102 T cell alloreactivity was dependent
on the recognition of an allopeptide presented by I-Ep.activity of the 1-F2 hybridoma was mapped to a region
between residues 447 and 478 of b-galactosidase using It also suggested that the specificity of the 2.102 TCR
for the allopeptide was strikingly different from its speci-a panel of overlapping peptides of 30 or 32 amino acids
(Figure 1A) and was further narrowed down to the region ficity for the Hb peptide, because the latter recognizes
only N at P5, and the library containing that residue didof residues 450±462 using a panel of overlapping 13-
mers (Figure 1B). The binding register of the b-gal(450± not stimulate it.
To fix the residues at P4 and P5, each of the 12 possi-462) epitope to I-Ep was deduced from the analysis of
amino acid substitutions on 1-F2 hybridoma response ble combinations of P4 and hydrophobic P5 residues
were synthesized and assayed for activity. Residues S(Figure 1C). The assignment of the putative binding reg-
ister was facilitated by a P1 pocket that is conserved and A were slightly better than T at position P4, correlat-
ing with their role as MHC anchors (data not shown). Sbetween I-Ek and I-Ep, since the residues structurally
involved in this pocket are nonpolymorphic between the was selected at P4 rather than A to improve solubility.
W at P5 was more active than I, regardless of the residuetwo molecules (Stern et al., 1994; Fremont et al., 1996).
The b-gal(450±462) epitope has an I as the P1 anchor present at P4, whereas L and V were 30±1000 times less
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Figure 2. Determination of the Structural Features of an Allomimo-
tope That Reconstitutes 2.102 T Cell Alloreactivity
(A) The capacity of two peptide libraries to reconstitute 2.102 T
cell hybridoma alloreactivity was analyzed on CHO-Ep cells. The
sequence of the libraries is GKKVIXX[S/T/A]UGXXS, where residue
U is a subset containing equimolar mixtures of the hydrophilic (K,
R, D, E, N, Q [crossed squares]) or hydrophobic (I, L, V, W 5 Uo
[crossed circles]) amino acids. At P4, an equimolar mixture of S, T,
and A was used. The I at P1, G at P6, and S at P9 were used as
MHC anchors and therefore set the binding register of the library.
The sequence GKKV, derived from the Hb(64-76) epitope, was used
as an N-terminal extension to increase the solubility of the libraries.
T cell hybridoma activation was measured by IL-2 production after
24 hr of culture using the CTLL-2 line as described previously (Eva-
vold et al., 1992). The values represent the mean 6 SD of triplicate
wells.
(B) Deconvolution of the stimulating peptide library P4 and P5 posi-
tions. Peptide libraries were synthesized with an S, T, or A at P4
and an I, L, V, or W at P5, for a total of 12 libraries. For clarity, only
results with S at P4 are shown.
(C±F) Deconvolution of the peptide libraries at positions P2 (C), P3
(D), P7 (E), and P8 (F). The peptide library GKKVIXXSWGXXS was
deconvoluted by synthesizing libraries in which the P2, P3, P7, or
P8 positions were individually replaced by one of the amino acid
subsets J (J1±J5). The subsets used were as follows: J1 5 [I, V, A,
M]; J2 5 [G, S, T, Abu]; J3 5 [F, Y, W, P]; J4 5 [K, R, H, L]; and
J5 5 [D, E, N, Q].
The bold line (A±F) represents the peptide library selected as optimal
for further rounds of peptide synthesis. The dashed line (C±F) repre-
sents stimulation by the Uo peptide library, described above in (A).
active than W (Figure 2B). Thus, S at P4 and W at P5 hand, three libraries at P7 and four libraries at P8 stimu-
lated to this level. These observations suggest that thewere selected for the next round of syntheses.
The optimal residues at positions P2, P3, P7, and P8 N-terminal half of the allopeptide is more critical for the
specificity of 2.102 TCR allorecognition.were assigned using a similar strategy, in which each
position was individually replaced by one of five amino An allopeptide (referred to as ªEPMº) with the optimal
residue at each position was synthesized and foundacid subsets (J1 to J5), followed by individual residues.
At P2, only the library with subset J2 (G, S, T, and Abu) to be a very potent stimulator of 2.102 T cells, with
concentrations as low as 0.3 ng/ml inducing a detect-produced strong stimulation (Figure 2C). The most ac-
tive residue at P2 in this subset was further defined as able response. EPM was I-Ep restricted, since no re-
sponse was observed when it was presented by I-EkT (data not shown). At P3, the library with subset J3 (F,
Y, W, and P) was favored over subset J1 (I, V, A, and (Figure 3A). The EPM and Hb(64-76) peptides were very
similar in their potential TCR-accessible residues (FigureM) (Figure 2D). The strong stimulation with the subsets
containing hydrophobic residues suggested that this 3B). In addition to the N-terminal four residues that were
intentionally kept the same, the residues at P2 and P8structural property is important at P3. F was shown to
be optimal at P3 (data not shown). At P7, the library also were identical. The major differences between the
peptides were in the central portion, where the A at P3with subset J2 stimulated slightly more strongly than J1
(Figure 2E), and S was subsequently identified as the and N at P5 in the Hb(64-76) peptide have been replaced
with the aromatic residues F and W, respectively. An-optimal residue at this position (data not shown). Four
of the five peptide libraries with a specific subset at P8 other substitution between the two peptides can be
observed at P7. It has been suggested that the absencestimulated the 2.102 alloresponse relatively well (Figure
2F), and the library containing the subset J1 stimulated of a P7 pocket in I-E molecules, in comparison to the
DR1 molecule, can be attributed to the presence in I-Ethe best. Because this subset contained the aliphatic
residues I and V, we included L in the analysis of the molecules of aromatic residues at b30 and b67 that
would fill this pocket (Fremont et al., 1996) and of aoptimal residue at this position and showed that it was
the optimal residue at P8 (data not shown). It is notewor- K-to-P substitution at b65 that would dramatically alter
the structure of the pocket (Schild et al., 1995). Interest-thy that only one library at P2 and two libraries at P3
stimulated 2.102 alloreactivity at levels similar to the ingly, the I-Ep residues b65 and b67 are conserved with
the equivalent DR1 residues. Thus, the P7 position of I-Ep±library with 20 amino acids (X) at the P2, P3, P7, and
P8 positions (Figures 2C±2F; dashed line). On the other restricted epitopes could actually be an MHC anchor
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observation, we sought to recapitulate the alloreactivity
of I-Ep by mutation of the I-Ek molecule. Six of the 20
differences between I-Ek and I-Ep are located on the b
chain a helix, and 14 are on the b strands of the peptide-
binding groove. We generated a mutant I-Ek molecule,
I-EkD6, in which the six residues on the b chain a helix
(60, 63, 65, 67, 70, and 71) were substituted by those
present in I-Ep. Thus, the I-EkD6 contains alloresidues on
the a helix, but retains an I-Ek peptide binding groove.
Transfection of CH27 cells with the I-EkD6 b chain recon-
stituted 2.102 T cell alloreactivity (Figure 3C). We con-
cluded that these substitutions in the a helix of the I-Ek
b chain have altered the specificity of the 2.102 TCR for
the pool of self peptides presented, and thus generated
novel functional ligands. These results demonstrate the
critical nature of these six MHC residues. More impor-
tantly, they allow us to utilize the Hb(64-76) peptide
and its available crystal structure in subsequent library
design. We know that the P3 and P5 residues are TCR
contact residues and are completely solvent accessible,
and that changes at these positions do not affect MHC
binding. Single substitutions at positions 60, 65, 70, and
71were also generated; however, none of them reconsti-
tuted 2.102 alloreactivity when transfected into CH27
cells (data not shown).
Allorecognition by the 2.102 TCR Is Degenerate
The activity of the library with a pool of hydrophobic
residues at P5 (Figure 2A), which has a theoretical com-
plexity of more than 106 different peptides, suggested
that numerous peptides could reconstitute 2.102 T cell
alloreactivity and, therefore, that allorecognition was de-
generate. This hypothesis was strengthened by the ob-
servation that libraries with complexities of 109 (I-X7-S)
or even 1011 (X9) stimulated the 2.102 T cell alloresponse
(Figure 4A). Interestingly, some residues must be critical
at key positions for allorecognition, because the library
with a subset of ten amino acids at nine positions (Z9)
did not stimulate the 2.102 T cell.Figure 3. EPM Is a Potent Stimulator of 2.102 T Cell Alloresponse
The recognition of W at P5 of EPM indicated that(A) The allopeptide with the optimal residue at each position,
the specificity of the 2.102 alloresponse was markedlyGKKVITFSWGSLS, was synthesized and is referred to as ªEPM.º
The activation of the 2.102 T cell hybridoma by the EPM peptide different from therecognition of the Hb peptide, because
presented either by CHO-Ep or CHO-Ek cells was assayed as de- the latter is exquisitely specific for a P5 N. To explore
scribed in the legend to Figure 2. further the issue of degeneracy in the recognition of P5,
(B) Alignment of 2.102 TCR peptide ligands. The sequences of
EPM libraries substituted with pools at P5were analyzedHb(64-76) (I-Ek±restricted) and EPM (I-Ep±restricted) peptides are
for their capacity to stimulate 2.102 T cell alloreactivity.shown.
All five pools stimulated the 2.102 T cells, albeit with(C) Expression of a mutated I-Ek in the B cell lymphoma CH27 recon-
stitutes a 2.102 T cell alloresponse. The I-Ek b chain was mutated different activities (Figure 4B). These data clearly dem-
for I-Ep residues in the a helix domain of the binding groove. The onstrate that the 2.102 TCR is very permissive to substi-
2.102 T cell hybridoma was stimulated with 105 APCs. tutions at P5 for the recognition of the alloligand. Taken
together, our results show that allopeptide recognition
residue. This hypothesis correlates with the observation by the 2.102 TCR is structurally different from its nominal
that libraries with a G, S, T, or even A (present in the antigen in the central portion of the peptide and that
subset J1), stimulated relatively strong 2.102 allore- there is an increased permissiveness to substitutions at
sponses (Figure 2E and data not shown). The EPM se- the P5 position of this allopeptide.
quence does not correspond to any currently known
murine sequences and therefore represents an alloepi-
Polymorphic Residues on the a Helix of I-Ep Altertope mimic.
the Specificity of 2.102 Recognition for
the Central Portion of the PeptideRecapitulation of I-Ep Alloreactivity
The 2.102 TCR specificity at positions P3 and P5 ofby Mutation of I-Ek
Hb(64-76) in the context of presentation by the I-Ek orNo crystal structure is available for peptide/I-Ep com-
I-EkD6 molecules was then investigated. We synthesizedplexes, making precise assignments of key residues dif-
ficult. To provide a more defined structural basis for our peptide libraries, derived from the Hb(64-76) epitope,
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libraries was even more heterogeneous when they were
presented in the context of I-EkD6 (Figure 5C). Noticeably,
the library with the aromatic residues (J3) at P3 stimu-
lated best. Furthermore, residue F was shown to be the
most active in this subset (data not shown). Overall,
these findings demonstrate that a change in the a helix
residues of the MHC molecule can dramatically alter the
specificity of TCR.
The interpretation of the previous data could have
been impaired by different biological phenomena, such
as peptides with mixed agonist/antagonist properties
(Racioppi et al., 1993) or compensatory changes in ago-
nist peptides (Ausubel et al., 1996, 1997), due to the
presence of heterogeneous residues at P3 and P5. To
eliminate these possibilities, comparison of the 2.102 T
cell response to I-Ek and I-EkD6 MHC molecules was
made using single Hb(64-76)F70 peptides substituted
at P5. Substitution of the A70 residue of Hb peptide with
a F increased 2.102 reactivity on both I-E molecules
(Figure 5E and 5F), thus increasing the sensitivity of
our assay. In addition, the increase in the 2.102 T cell
response to the F70-substituted peptide was greater on
I-EkD6 than I-Ek, again supporting the hypothesis of a
shift in the TCR recognition. More importantly, the 2.102
T cell response was extremely sensitive to substitution
at P5 in the context of I-Ek presentation (Figure 5E).
In contrast, all of the position 72 substitutions were
tolerated well in the context of I-EkD6 presentation (Figure
5F). This finding conclusively demonstrated that the a
helix polymorphic residues of an allogeneic MHC mole-
cule can alter the fine specificity of the TCR.
Specificity in Allorecognition
by the 2.102 TCR CDR3a
One possible explanation for this allorecognition is sim-
ply a loss of involvement by the CDR3 regions of theFigure 4. Allorecognition by the 2.102 T Cell Is Degenerate
TCR. To address this issue, the reactivity of Hb(64-76)-(A) The potential of peptide libraries with different complexities was
specific T cell hybridomas derived from mice transgeniccompared. The library Uo is described in the legend to Figure 2A.
for the 2.102 TCR b chain was examined (Hsu et al.,The library I-X7-S was synthesized with the MHC anchors previously
identified at P1 and P9 and a mixture of 20 amino acids (X) from P2 1995, 1996). These hybridomas, which use the 2.102
to P8. The libraries Z9 and X9 were degenerated at all nine positions. TCR b chain and the same or similar Va and Ja genes
(B) The 2.102 TCR can tolerate multiplesubstitutions at P5 for recog- as 2.102, but different CDR3a regions, were tested for
nition of EPM. Peptide libraries in which the P5 residue (W) of EPM
their reactivity to the EPM/I-Ep complex (Table 1). Thewas substituted with one of the J* amino acid subsets were synthe-
hybridomas CST.6.4 and MNC.2.4 were activated bysized. The subsets J2 and J4 were used as described in the legend
both EPM/I-Ep and Hb(64-76)/I-Ek complexes. In con-to Figure 2. The other subsets were modified as follows: J1* 5 [V, A,
M]; J3* 5 [F, Y, P]; and J5* 5 [D, E, Q]. Activation of the 2.102 T cell trast, the hybridomas HYD.1.8 and LNX.2, which differ
hybridoma was assayed as described in the legend to Figure 2. from the preceding reactive hybridomas by only 3 amino
acids, including 2 prolines, were not stimulated by EPM.
Thus, these results demonstrate the critical role of the
where either P3 or P5 positions were substituted with
CDR3a in the 2.102 T cell alloresponse, and highlight
one of the amino acid subsets (J1±J5) while the other
the specificity of this interaction.
position was substituted with a pool of 20 amino acids.
Only the library substituted at P5 with the subset con-
taining the critical residue N (J5) stimulated the 2.102 T Discussion
cell response in the context of I-Ek (Figure 5B). In striking
contrast, all five libraries stimulated 2.102 T cells when Our study permits a direct comparison of peptide li-
gands recognized by a single TCR in the context of MHCpresented in the context of I-EkD6 (Figure 5D). These
results extend our previous observation on 2.102 TCR class II self-restricted and allogeneic responses. We
have shown that polymorphic residues located on therecognition of the EPM/I-Ep complex, which showed a
similar lack of specificity at the P5 positionof thepeptide a helices of I-E molecules can dramatically broaden the
TCR specificity for the central portion of the epitope.(Figure 4B). All five libraries with subsets at P3 stimu-
lated a 2.102 T cell response when presented in the The findings are not compatible with either of the two
models for the role of the peptide in allorecognition. Ourcontext of I-Ek, although three of them were more active
(Figure 5A). However, the 2.102 T cell response to these results instead fit with the model in which both MHC
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Figure 5. Interaction of the 2.102 TCR with
Polymorphic Residues on the MHC Molecule
a Helix Alters Its Peptide Specificity
(A±D) The response of the 2.102 T cell to
Hb(64-76) peptide libraries substituted at P3
and P5 was evaluated in the context of pre-
sentation by I-Ek andI-EkD6. The peptide librar-
ies synthesized were based on the Hb(64-76)
peptide sequence. One set of peptide librar-
ies (A and C) was substituted at the P3 posi-
tion with one of the amino acidsubset J, while
the P5 position was substituted with a pool
of 20 amino acids (X). Another set of libraries
(B and D) was substituted at P3 with X and
at P5 with the J subsets.
(E and F) The degenerate recognition of the
Hb(64-76) P5 position in the context of the
allogeneic MHC molecule I-EkD6 was analyzed
with HPLC-purified peptides. The positions
P3 (A70) and P5 (N72) of the Hb(64-76) pep-
tide were substituted with F and the indicated
amino acids, respectively. The Hb(64-76) pep-
tide with a single F substitution at P3 was also
assayed. Activation of the 2.102 T cell hybrid-
oma was assayed as described in the legend
to Figure 2 using the cell lines CHO-Ek (A, B,
and E) or CHO-EkD6 (C, D, and F) as APCs.
and peptide residues are recognized by the TCR, in a and second, in contrast to class I systems, APCs that
can exclude the contribution from endogenous peptidesmanner similar to that of self-restricted responses. The
difference is that the polymorphic residues located on are not available in class II systems. This observation
also suggests that the TCRVb1 segment of the 2.102the a helices of allogeneic MHC molecules contribute
additional interactions, thereby changing the role of TCR plays a major role in the allorecognition of I-Ep,
although a contribution from the TCRVa segment is es-peptide residues in the overall interaction of the TCR
with the peptide/MHC complex. Therefore, more energy sential, as demonstrated by the experiments with the T
cell hybridomas bearing substitutions in their TCR ais provided by the TCR/MHC interactions, and less from
the TCR/peptide interactions; however, the latter are chain (Table 1). Clearly, there will be extreme cases in
which only the peptide or only the MHC molecules arestill necessary to reach the threshold required for T cell
activation. We contend that this may be the most com- recognized, but these would represent a minority of the
responses.mon form of allorecognition.
To support this hypothesis, we compared the allore- Our findings support the concept that for any given
alloreactive T cell, there are likely to be several differentsponse of an oligoclonal T cell population derived from
2.102 TCR b chain±only transgenic mice (Hsu et al., self-peptides that could generate the alloligand. Indeed,
it was recently reported that a complex array of peptides1995) to 2.102 TCR ab transgenic mice. The response
of the b chain±only transgenic T cells to the Hb(64-76) is recognized in MHC class I±restricted alloreactive re-
sponses (Wang et al., 1998). The ability of multiple pep-peptide was much weaker than that of 2.102-ab T cells;
however, T cells from both responded strongly to the tides to form an alloligand greatly increases the proba-
bility that a given T cell will be alloreactive. Thus, wealloligand I-Ep (C. D. and P. M. A., unpublished data).
This observation suggests again that allorecognition is propose that the majority of alloreactivity represents a
variation of self-restricted responses, in which there isless stringent than self-restrictedTCR recognition.How-
ever, we were unable to resolve the specificity of this a shift in the relativecontribution of theMHC and peptide
residues toward the overall strength of binding betweenbulk alloresponse against I-Ep, for two reasons: first, the
CHO cells were inefficient at stimulating primary T cells, the TCR and MHC/peptide ligand.
Peptide Recognition in Class II Alloreactivity
549
generate an alloresponse (Chattopadhyay et al., 1994;Table 1. The Alloresponse to the EPM/I-Ep Complex Is CDR3a
Specific Joyce and Nathenson, 1996). Nevertheless, structural
changes of the MHC molecule induced by substitutionsEC40 (nM)T Cell in the peptide-binding groove or specific peptide bind-
Hybridoma Va Gene N Ja EPM Hb(64-76) ing have been suggested (Catipovic et al., 1992; Blue-
stone et al., 1992; Pease et al., 1993; Wen et al., 1996).CST.6.4 AV4S13 SAG AJ48 20 0.3
We can speculate that these altered MHC moleculesMNC.2.4 AV4S13 SGD AJ48 30 2.0
could change the specificity of the T cell repertoire byHYD.1.8 AV4S2 SPP AJ48 .1000 3.0
a mechanism similar to the one described in this studyLNX.2 AV4S13 TPP AJ48 .1000 3.0
and be responsible for alloreactivity. Modeling of a sub-
2.102 AV4S14 VTD AJ48 0.03 2.0 stituted Hb peptide presented by the allogeneic I-EkD6
T cell hybridomas derived from 2.102 TCR b chain only±transgenic illustrates a possible relationship between the degener-
mice and characterized previously were used as described (Hsu et acy in the recognition of the central region of the peptide,
al., 1996). The deduced amino acid sequence of their TCR a chain the polymorphic residues on the MHC a helices, and the
V-J junction, indicated in single-letter code, as well as the gene TCR CDR loops (Figure 6). It shows the proximity of the
usage for this chain (Hsu et al., 1996), are shown. The V-J junction
MHC a helix residues 67, 70, and 71 with position P5 ofsequence and the gene usage of the 2.102 TCR a chain is also
the peptide.shown below. The HYD.1.8 and LNX.2 Va sequences also differed
at a second site in the framework region, away from the CDR loops There are several possibilities as to how this broaden-
(Chothia et al., 1988; Hsu et al., 1996). These hybridomas were ing of the peptide recognition could occur. For example,
stimulated with different dilutions of the EPM or Hb(64-76) peptides the TCR could reposition itself onto the peptide/MHC
using CHO-Ep or CHO-Ek cells as APCs, respectively. The EC40 was surface, changing the way the CDR3 loops recognizecalculated as the concentration of peptide required to achieve 40%
the central region of the peptide. This repositioningof the maximal IL-2 production by the hybridomas, as determined
could range from a minor shift or a complete 1808 rever-by CTLL-2 assay.
sal (Sun et al., 1995; Garboczi et al., 1996; Garcia et al.,
1996; Sant'Angelo et al., 1996; Loftus et al., 1997; Sim
Examples of degenerate recognition of MHC alloli- et al., 1997). However, preferential use of Va or Vb gene
gands have been recently reported (Brock et al., 1996; segments in some T cell responses suggest that the
Burrows et al., 1997). In the 2C allomimitope system, it CDR1 and CDR2 regions would interact with the MHC
has been shown that there is no similarity between the molecule in a defined and limited mode (McHeyzer-Wil-
alloligand and a foreign antigen mimitope (Udaka et al., liams and Davis, 1995; Sant'Angelo et al., 1996). Alterna-
1992; Brock et al., 1996; Garcia et al., 1996; Schlueter tively, the 2.102 TCR could bind the I-Ep or I-Ek surfaces
et al., 1996; Tallquist et al., 1996). However, a direct
in the same orientation while the allogeneic MHC resi-
relationship between this phenomenon and polymor-
dues cause some reorientation of only the CDR3 loop(s).
phism of allogeneic MHC molecules was not established
This CDR3 reorientation could result in more flexible
in these studies. Polymorphism in the MHC a helices
recognition. Our observation that the presence of P resi-
that lead to alloreactivity have been reported both for
dues in the CDR3a loop abrogates I-Ep alloreactivity is
class I (Grandea and Bevan, 1992) and class II alloanti-
consistent with some type of reorientation of the CDR3
gens (Lombardi et al., 1989; Dellabona et al., 1991; Cop-
loops.
pin et al., 1993). The example of the H-2bm12 is particularly
It is also intriguing tospeculate that MHC polymorphicrelevant to our studies (McKenzie et al., 1979). This natu-
residues could change recognition specificity, not onlyrally occurring class II mutant, which differs from I-Ab
in allo but also in self-MHC-restricted responses. Theat three positions (b67, b70, and b71), generatesa strong
residues b67, b70, and b71 of the class II moleculesalloresponse in H-2b mice (Bill et al., 1989). These three
have been identified as part of a ªshared epitope,º whichsubstitutions are at positions identical to those found
correlates with increased susceptibility to rheumatoidin I-EkD6. We contend that these I-Abm12 alloreactive T
arthritis (Penzotti et al., 1996). Changes in these residuescells are analogous to the 2.102 T cells in that the MHC
could affect T cell repertoire development by alteringresidues provide additional binding energy to the TCR/
the role of the peptide, leadingto an increased frequencyligand interaction, resulting in a greater number of pep-
of autoreactive T cells. Peptide residues outside of thetides that can be recognized by each T cell. Thus, the
groove have also been shown toaffect Tcell recognition,high frequency of alloreactive T cells may be explained
and by binding to the TCR and providing additional bind-in part by the increased probability that a T cell will find
ing energy, these residues could affect the recognitionan alloligand, due to the broadened peptide specificity
of the central region of the peptide (Carson et al., 1997).created by altered MHC a helix contacts (Sherman and
Furthermore, this interplay between the MHC a helicesChattopadhyay, 1993).
and CDR3s specificity would functionally increase TCRThese observations potentially influence many differ-
diversity; a given TCR ab heterodimer would have aent aspects of T cell biology, particularly relating to the
different fine specificity depending on the MHC withinteraction of the TCR with its ligand. They show that
which it interacts. This could influence, either positivelyallorecognition can be similar to foreign antigen recogni-
or negatively, the generation of theperipheral repertoire.tion, with the exception that the allogeneic MHC resi-
Overall, these findings indicate that the TCR recognitiondues have affected the specificity of the TCR, so that
of a ligand is not simply a static process, and show thatmany different peptides can be recognized. Clearly, this
changes in one portion of the ligand are able to affectobservation does not account for all alloreactivity, be-
cause changes in the MHC binding groove alone can dramatically the recognition other portions of the ligand.
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Figure 6. A Model of Hb(64-76)F70,W72 Bound to I-EkD6
(Left) A ribbon diagram of a top view of the peptide/MHC surface with the b chain helix on the bottom. The peptide P21 to P9 is shown in
light blue; the P3 and P5 side chains are depicted in yellow; and the six substituted MHC residues from I-Ek are shown in red. (Right) A space-
filling model of the same view, keyed with the same colors.
Experimental Procedures polymerase chain reaction (PCR) protocol and pI-Ekb vector (Raci-
oppi et al., 1991) as template DNA. Adjacent primers at codons
T Cell Hybridomas 68±69 were selected for mutagenesis: forward primer, codons
The T cell hybridoma 2.102, specific for the Hb(64-76)/I-Ek complex 69±77: GAGCGAAGGCGGGCCGAGGTGGACACG; reverse primer,
and alloreactive against I-Ep, has been described previously (Eva- codons 68±55: TAGAAGCTCCTTCTGGTTGTTCCAATACTCGGCGT
vold et al., 1994; Daniel et al., 1998). T cell hybridomas specific CTGGCCG (the nucleotide substitutions relative to the I-Ek b chain
for the I-Ep±restricted b-galactosidase epitopes were generated as are underlined). A silent mutation (indicated with bold), was also
described previously (Lorenz and Allen, 1988). In brief, B10.P mice introduced to generate a novel XbaI restriction site at the oligonucle-
(a kind gift from Ted Hansen) were immunized with 50 mg of purified otide junction. The pI-Ekb vector was amplified for 20 cycles of
b-galactosidase (Boehringer Mannheim) emulsified in complete denaturation at 948C for 15 s, annealing at 688C for 30 s, and exten-
Freund's adjuvant. Ten days later, draining popliteal lymph node sion at 748C for 3 min, using 50 pmol of primers and VentR polymer-
cells were cultured in vitro for 4 days with 20 mg/ml b-galactosidase ase (New England Biolabs, Beverly, MA) in the manufacturer's buffer
and fused with the BW5147a2b2 thymoma according to a standard supplemented with 2 mM MgSO4 and 200 mM dNTPs. The linear,
protocol (Allen, 1987). The clonal hybridomas weretested for antigen full-length pI-EkD6b PCR product was subjected to DpnI digestion
specificity using the transfected B cell line CH27-Ep as APCs (Daniel for 1 hr at 378C. The vector was then gel purified, kinased, and self-
et al., 1998). The epitope recognized by these hybridomas was ligated. The I-EkD6 b chain was finally subcloned into the expression
mapped using a panel of overlapping peptides (30-mers and 13- vector pBSRaEN. The validity of this construction was confirmed
mers). The I-Ep±binding register of the epitope identified was deter- by DNA sequencing.
mined by amino acid substitution analysis (alanine scan and conser-
vative/nonconservative replacement). Generation of CHO-Ep, CHO-Ek, and CHO-EkD6 Cell Lines
The I-Eka and I-Ek b chains were subcloned from pI-Eka and pI-Ekb
Peptides vectors (Racioppi et al., 1991) into pBSRaEN expression vectors
The peptides were synthesized using standard FMOC (fluorenyl- (Daniel et al., 1998). CHO cells (3 3 105) were transfected with 1.25
methoxycarbonyl) chemistry on a Rainin Symphony Multiplex pep-
mg of pBSRaEN-Eka and 1.25 mg of either pBSRaEN-Epb (Daniel
tide synthesizer. The peptide pools consisted of equimolar ratios et al., 1998), pBSRaEN-Ekb, or pBSRaEN-EkD6b vectors using the
of each amino acid, and each position was double coupled. The DOSPER lipofectin procedure according to the manufacturer's in-
single-sequence peptides were purified by HPLC and their composi- structions (Boehringer Mannheim, Indianapolis, IN). Geneticin-resis-
tion confirmed by mass spectrometry and amino acid analysis. Pep-
tant lines were stained with the anti-Ea mAb 14-4-4s and cell sorted
tide and library sequences are represented with the standard single-
for similar levels of I-E expression using a FACSVantage (Becton-letter code, with the exception that the letter X represents a mixture
Dickinson, Mountain View, CA).of all 20 natural amino acids where the C residue has been replaced
by a-aminobutyric acid. The letter Z represents an equimolar mixture
Modeling of the I-EkD6/Hb(64-76)F70,W72 Structureof the following ten amino acids: K, D, L, T, A, N, Y, M, H, and P.
A model of I-EkD6/Hb(64-76)F70,W72 was generated using the Insight
II suite of programs (MSI, San Diego, CA). The model was basedT Cell Hybridoma Assay
on the I-Ek/Hb crystal structure (Fremont et al., 1996) and involvedCH27, CH27-Ep, CHO-Ep, CHO-Ek, or CHO-EkD6 cell lines were used
replacement of eight side chains. The modeling also was facilitatedas APCs (3 3 104/well) where indicated. The T cell hybridomas were
by residues similar or identical to those being added, found in thestimulated in 96-well plates with serial dilutions of peptides and
published crystal structures of I-Ek/HSP (Fremont et al., 1996) orAPCs. The interleukin-2 (IL-2) production was assayed using the IL-
DR1/HA (Stern et al., 1994). Each of these residues (AP3F, NP5W,2±dependent cell line CTLL-2 as described previously (Evavold et
N60Y, S63N, P65K, F67L, Q70R, and K71R) was replaced and thenal., 1992).
positioned into the same rotamer found in either the I-Ek/HSP or
DR1/HA structure. Energy minimization studies, performed usingI-Ek Mutagenesis
the Discover module software (MSI), indicated that the model wasThe I-Ek b chain was mutated to I-Ep residues at position 60 (N→Y),
63 (S→N), 65 (P→K), 67 (F→L), 70 (Q→R), and 71 (K→R) using a energetically favorable.
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